Top Markets
Coin of the day
Sangamo Therapeutics, Inc. Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

GBY
Rank in Stocks #11086
Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing genomic medicines designed to significantly improve patients' lives. The company employs cutting-edge platform technologies, including gene therapy, cell therapy, genome editing, and genome regulation. Central to their technological approach is the zinc finger protein (ZFP) platform, which provides both ZFP nucleases for precise DNA sequence modification (allowing for gene addition or knockout) and ZFP transcription factors for upregulating or downregulating gene expression. Their development pipeline includes SB-525, currently in a Phase III AFFINE clinical trial for hemophilia A; ST-920, a gene therapy in Phase I/II STAAR trials for Fabry disease; and SAR445136, a cell therapy undergoing Phase I/II PRECIZN-1 trials for sickle cell disease. Additionally, Sangamo is advancing TX200, a chimeric antigen receptor for HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy targeting cancer; ST-501 for tauopathies; and ST-502 for synucleinopathies, which include Parkinson's disease and other neuromuscular disorders. The company maintains extensive collaborative and strategic partnerships with prominent organizations such as Biogen MA, Inc., Pfizer Inc., Sanofi S.A., Novartis Institutes for BioMedical Research, Inc., and F. Hoffmann-La Roche Ltd. Originally incorporated in 1995 as Sangamo BioSciences, Inc., the company adopted its current name in January 2017 and is headquartered in Brisbane, California.
Share Price
$5.21
Last synced: 2022-08-11
Market Cap
$745.49M
Change (1 day)
0.15%
Change (1 year)
0.00%
Country
US
Trade Sangamo Therapeutics, Inc. (GBY)

Category

Stock price history for Sangamo Therapeutics, Inc. (GBY)
Highest end of day price: $4.90 on 2022-08-01

Lowest end of day price: $13.01 on 2007-12-01
Stock price history of Sangamo Therapeutics, Inc. from 2007 to 2026
Annual Stock Price Performance
Year Performance
2022 -39.40%
2021 -39.13%
2020 183.16%
2019 -2.27%
2018 -3.94%
2017 12.23%
2016 -3.19%
2015 -11.69%
2014 -9.95%
2013 4.54%
2012 107.38%
2011 -56.82%
2010 28.16%
2009 105.10%
2008 -81.94%
2007 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH